Trial Details
COMPLETEDBasic Information
| Clinical ID | c1579 |
|---|---|
| Identifier | NCT00810030 |
| Trial Title | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Anemia|Iron Deficiency|Iron-Deficiency Anemia|Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Ferric carboxymaltose|DRUG: Iron Sucrose |
Participant Information
| Sponsor | Vifor Pharma |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-08 |
|---|---|
| Primary Completion Date | 2025-12-09 |
| Completion Date | 2025-04-10 |